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ABSTRACT
Objective: Activation of nuclear factor kappaB by diverse bacteria regulates the secretion of 
chemokines and cytokines. Staphylococcus aureus (S. aureus)-infected osteoblasts can significantly 
increase the secretion of interleukin-6 and monocyte chemoattractant protein-1. The aim of this study 
was to investigate whether S. aureus can activate nuclear factor kappaB in human osteoblasts, and 
whether the activation of nuclear factor kappaB by S. aureus regulates the secretion of interleukin-6 
and monocyte chemoattractant protein-1. Methods: Immunoblot and electrophoretic mobility shift 
assay were used to detect the degradation of IκBa and activation of nuclear factor kappaB in human 
osteoblasts in response to S. aureus, respectively. Enzyme-linked immunosorbent assay was used to 
measure the secretion of interleukin-6 and monocyte chemoattractant protein-1 in the supernatants. 
Lastly, carbobenzoxyl-l-leucinyl-l-leucinyl-l-leucinal, an inhibitor of the nuclear factor kappaB, was 
used to determine if activation of nuclear factor kappaB by S. aureus in human osteoblasts regulates 
the secretions of interleukin-6 and monocyte chemoattractant protein-1. Results: Our results for the 
first time demonstrated that S. aureus can induce the degradation of IκBa and activation of nuclear 
factor kappaB in human osteoblasts in a time and dose-dependent manner. In addition, inhibition 
of nuclear factor kappaB by carbobenzoxyl-l-leucinyl-l-leucinyl-l-leucinal suppressed the secretion of 
interleukin-6 and monocyte chemoattractant protein-1 in the supernatants of S. aureus-infected hu-
man osteoblasts in a dose-dependent manner. Conclusions: These findings suggest that S. aureus 
can activate nuclear factor kappaB in human osteoblasts, and subsequently regulate the secretion 
of interleukin-6 and monocyte chemoattractant protein-1. The nuclear factor kappaB transcription 
factor regulates a number of genes involved in a wide variety of biological processes. Further study of 
the effects of nuclear factor kappaB activation on S. aureus-infected human osteoblast may provide 
us new insights into discovery of the immune mechanisms in osteomyelitis. 
Keywords: Staphylococcus aureus; osteoblasts; NF-kappaB; interleukin-6; chemokine CCL2.
[Braz J Infect Dis 2011;15(3):189-194]©Elsevier Editora Ltda.
INTRODUCTION
Osteomyelitis is a severe infection of bone tis-
sue, which results in progressive inflammatory 
destruction of bone. Staphylococcus aureus is 
known as an important causative organism in 
osteomyelitis,1,2 which accounts for approxi-
mately 80% of all human cases.2 Recent works 
have demonstrated that S. aureus-infected os-
teoblasts can secrete a number of cytokines and 
chemokines to mediate the immune responses 
in osteomyelitis.3-6 However, to date, the patho-
genesis of immune responses in S. aureus-in-
duced osteomyelitis is still poorly understood. 
The activation of nuclear factor kappaB 
(NF-κB) signaling pathway to produce inflam-
matory mediators plays an essential role in 
the host response to pathogenic organisms.7 
NF-κB is a dimeric protein composed of 
members of the Rel / NF-κB family, and NF-
κB dimers are retained into the cytoplasm by 
the inhibitory protein IĸBa.8 Different stimuli 
can induce the phosphorylation of IκBa, and 
its subsequent ubiquitination and degrada-
tion.9 Freed NF-κB can translocate into the 
nucleus, leading to the transcriptional acti-
vation of NF-κB-dependent genes,10 such as 
chemokines and cytokines genes.11 Previous 
studies have demonstrated that NF-κB in eu-
karyocyte could be activated by diverse bacte-
ria, such as Porphyromonas gingivalis,12 Strep-
tococcus pyogenes,13,14 or Mycobacterium bovis 
Bacillus Calmette-Guerin (BCG).15 
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However, it is not clearly defined whether S. aureus 
infection can induce the activation of NF-κB in human 
osteoblasts. Interleukin-6 (IL-6) is a pleiotropic cytokine 
and plays important role in the regulation of immune 
response and inflammation,16 which controls the devel-
opment of both humoral and cell-mediated immune re-
sponses17 and block the suppressive activity of regulatory 
CD4+CD25+ regulatory T-cells,18 thereby enabling the 
progression of immune responses. Monocyte chemoat-
tractant protein (MCP)-1 is a small cytokine belonging 
to the CC chemokine family that is also known as CCL2 
(c-c chemokine ligand 2),19 which can induce the recruit-
ment of macrophages and activated T-lymphocytes into 
areas of inflammation or infection, and sustain inflamma-
tory responses by maintaining the activated status of such 
cells.20 The previous studies have confirmed that S. aureus-
infected human osteoblasts can significantly augment 
MCP-1 and IL-6 secretion in vitro,3,4 in vivo and in clinical 
human osteomyelitic lesions.21,22 It is unknown, however, 
the mechanism of IL-6 and MCP-1 immune responses to 
infection of S. aureus. Thus, in our present study, we in-
vestigated whether S. aureus can activate NF-κB signaling 
pathway, and whether such activation regulate the secre-
tion of IL-6 and MCP-1 in human osteoblasts. 
MATERIALS AND METHODS
Bacteria, human osteoblasts and culture conditions
S. aureus UAMS-1 (ATCC 49230), a human osteomyelitis 
clinically isolated strain23 was used in this study. S. au-
reus ATCC 49230 was obtained from the American Type 
Culture Collection. S. aureus cells were grown overnight 
(16 h) in 5 mL of Tryptic Soy Broth (Oxoid, Basingstoke, 
UK) in a shaking water bath at 37°C. The bacteria were 
harvested by centrifugation for 10 min at 4,300 × g at 
4°C and washed twice in 5 mL of Hank’s Balanced Salt 
Solution. The pellets were then resuspended in 5 mL of 
growth medium lacking antibiotics and antimycotics. 
The SV40 human osteoblasts (SV40 hOBs, ATCC) 
were obtained from the American Type Culture Collec-
tion. These cells were previously characterized as authen-
tic osteoblasts.24 The cells were seeded in 25-cm2 flasks 
and incubated at 37°C in 5% CO2 with DMEM/F12 (Gib-
co) supplemented with 0.3 mg/mL G418 (Sigma) and 10% 
fetal bovine serum (HyClone). Then, the cells were propa-
gated as described by the manufacturer. Once osteoblasts 
reached approximately 80% confluency, cells were trypsi-
nized (0.025% trypsin-0.01% EDTA), washed in medium 
and seeded into 6-well plates. Two to three hours before 
the addition of bacteria, the cells were washed twice with 
PBS and then incubated with an assay medium (growth 
medium without antibiotics and antimycotics) and in-
fected as described in the following section.
Infection assay
To investigate the IκBa degradation and NF-κB activa-
tion following infection, 2×106 cells/well were exposed to 
S. aureus for the designated times and at the indicated 
multiplicity of infections (MOI). To investigate the se-
cretion of IL-6 and MCP-1 in the supernatant of human 
osteoblasts infected with S. aureus, 2×106 cells/well were 
infected with S. aureus at an MOI of 250 (250:1 bacte-
ria/osteoblasts) or without S. aureus (controls) for 1 h. 
Following infection, the cells were washed with PBS and 
grown in DMEM/F12 supplemented with 0.3 mg/mL 
G418 and 10% fetal bovine serum for 24 h at 37°C in a 
5% CO2 atmosphere. To determine whether S. aureus-
activated NF-κB signaling pathway regulates the IL-6 
and MCP-1 secretion in the supernatants of human os-
teoblasts, 2×106 cells/well were pretreated with carboben-
zoxyl-l-leucinyl-l-leucinyl-l-leucinal (Z-LLL-al) (Sigma), 
an inhibitor of NF-κB,12 for 1 h, and then washed, added 
bacteria at an MOI of 250. Z-LLL-al is also named the 
proteasome inhibitor MG132 which can inhibit NF-κB 
formation and degradation of its inhibitor I-κB.25
Immunoblot assay 
After infection, cells were then washed once in PBS and 
lysed in cold buffer containing 50 mM Tris (pH 8.0), 
110 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF), 50 mmol/L NaF 
and 0.1 mmol/L sodium vanadate. The lysates were cen-
trifuged at 15,000 × g for 15 min at 4°C and the concen-
trations of the protein were determined with the Brad-
ford assay (Bio-Rad, Hercules, CA). Whole cell lysates 
were boiled in equal volumes of loading buffer (125 mM 
Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, and 10% 2-mer-
captoethanol) for 5 min. The protein extracts (50 µg each) 
were separated by 10% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred onto polyvinylidene difluoride (PVDF) mem-
brane (Pall Gelman Laboratory, Ann Arbor, MI). The 
membranes were blocked with 10% nonfat dried milk in 
Tris-buffered saline (TBS) for 1 h at room temperature, 
washed with TBST (Tris buffered-saline Tween-20) for 
3 × 5 min, and incubated with rabbit polyclonal anti-hu-
man IĸBa (Cell Signaling Technology, Danvers, MA) at a 
dilution of 1:200 for 45 min at room temperature. After 
hybridization with primary antibody, the membrane was 
washed with TBST three times. The membranes were then 
incubated with horseradish peroxidase-conjugated goat 
anti-rabbit immunoglobulin G (Cell Signaling Technol-
ogy) at a dilution of 1:10,000 in TBST for 30 min at room 
temperature and washed with TBST three times, and the 
antigens were detected with an enhanced chemiluminescence 
(ECL) detection system (Amersham, Piscataway, NJ, USA) 
and exposed to photographic film. 
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Electrophoretic mobility shift assay (EMSA)
After infection, nuclear extracts were prepared using rea-
gents from the NE-PER extraction system (Pierce, Rock-
ford, IL), as recommended by the manufacturer’s instruc-
tions. Then the nuclear extracts were used to test for NF-κB 
protein/DNA binding by a DIG Gel-Shift Kit (Roche, Ger-
many). The sequences for NF-κB were 5’-AGTTGAGGG-
GACTTTCCCAGGC-3’ (sense) and 5’-GCCTGGGAAA-
GTCCCCTCAACT-3’ (antisense). Briefly, equal molar of 
complementary NF-κB oligonucleotides were mixed in 
TEN-buffer [10 mM Tris–Cl, 1 mM EDTA, and 0.1 M NaCl 
(pH 8.0)] and incubated at 95°C for 10 min. After slowly 
cooling down to room temperature, double-stranded (ds) 
oligonucleotides were diluted with TEN-buffer to a final 
concentration of 3.85 pmol/μL. Labeling reaction was done 
in a final volume of 20 μL containing 1 μL ds oligonucleo-
tides, 9 μL water, 4 μL 5 × labeling buffer, 4 μL CoCl2 solu-
tion, 1 μL DIG-ddUTP and 1 μL terminal deoxynucleotide 
transferase. The reaction mixture was incubated at 37°C 
for 15 min and chilled on ice immediately. Labeling reac-
tion was stopped by 2 μL 0.2 M EDTA (pH 8.0). The labeled 
NF-κB oligonucleotides were diluted to 0.155 pmol/μL by 
adding 3 μL double distilled water. For gel shift analysis, a 
small aliquot was further diluted to 15.5 fmol/μL. In the gel 
shift assay, 5 μg nuclear extract were incubated with 4 μL 
binding buffer [5 mM EDTA, 50 mM (NH4)2SO4, 5 mM 
dithiothreitol (DTT), 1% Tween 20 (v/v), 150 mM KCl, 
100 mM Hepes (pH 7.6)], 1 μL poly (dI-dC) and 1 μL poly-
L-lysine. Double distilled water was added to a final reaction 
volume of 18 μL. To confirm the specificity of NF-κB protein/
DNA binding by competition assay, we added 100-fold ex-
cess unlabeled NF-κB oligonucleotides (cold probes) in the 
reaction mixture. After 5 min incubation at room tempera-
ture, 2 μL DIG-labeled NF-κB -oligonucleotides were added 
into the reaction mixture and incubated for another 30 min. 
After adding 5 μL loading buffer, the reaction mixture was 
fractionated in a 6% native polyacrylamide gel in 0.5 × TBE 
buffer and electroblotted onto Hybond-N+ membranes 
(Amersham Biosciences). After blotting, the membrane 
was baked at 120°C for 30 min and rinsed in washing buffer 
[0.1 M maleic acid, 0.15 M NaCl, 0.3% Tween 20 (pH 7.5)]
for 5 min, and then incubated for 30 min in blocking solu-
tion (1% blocking reagent in maleic acid buffer). Following 
incubation with anti-DIG-AP (1:10,000) in blocking solu-
tion for 30 min, the membrane was washed 2 × 15 min in 
washing buffer and equilibrated in detection buffer [0.1 M 
Tris–HCl, 0.1 M NaCl (pH 9.5)] for 5 min. Chemilumines-
cence signals were detected with CSPD as the substrate in 
X-ray film.
IL-6 and MCP-1 secretion assay 
After infection, the culture supernatants were collected 
and centrifuged (10,000 × g, 5 min). Then IL-6 and MCP-
1 in the culture supernatants were measured with enzyme-
linked immunosorbent assay (ELISA) kits for human IL-6 
or MCP-1 (R&D Systems, Minneapolis, MN), according to 
the manufacturer’s instructions. Each sample was assayed in 
duplicate and absorbance was determined at 450 nm. 
Data analysis
All assays were repeated in three independent experiments. 
Data are presented as mean ± SD. Statistical analysis among 
groups was performed by ANOVA and SNK test using the 
SPSS17.0 software package. Statistically significant values 
were defined as p < 0.05.
RESULTS
S. aureus induced IκBa degradation and NF-κB activation in 
human osteoblasts in a time-dependent manner.
In order to relate the kinetics of infection to the stabil-
ity of IκBa in human osteoblasts, human osteoblasts were 
infected with S. aureus at an MOI of 250 for indicated times. 
The infected cell lysates showed a quick IκBa degradation 
after 15 min and with a nearly loss of immunoreactivity at 
30 min, and nearly removed the prior levels at 60 min. How-
ever, uninfected cells had stable levels of IκBa expression 
(Figure 1A). 
To correlate the degradation of IκBa with the nuclear 
translocation of NF-κB in human osteoblasts, EMSAs were 
used to investigate the nuclear translocation of NF-κB. As 
shown in Figure 1B, nuclear proteins from the cells infected 
with S. aureus stimulated NF-κB DNA binding activity to 
rise at 30 min, reached the maximal level at 45 min, nearly 
loss at 90 min at an MOI of 250, whereas nuclear proteins 
Figure 1: Time-dependent activation of NF-kB signaling 
pathway by Staphylococcus aureus in human osteoblasts. 
Human osteoblasts were either uninfected (0 min) or infected 
with Staphylococcus aureus at a multiplicity of infections (MOI) 
of 250 for the indicated times. Immunoblot demonstrated 
cytosoic IkBa degradation (A) and EMSA showed nuclear 
NF-kB activation (B) in human osteoblasts. The exposed film is 
representative of results from three independent experiments.
IkBa
Actin
Time  
(min)
0 15 30 45 60
A B
NF-kB
Time (min) 0 30 45 60 90 45 
Cold probe - - - - - 100X
Ning, Zhang, Guo et al.
192
from uninfected cells nearly failed to display binding ac-
tivity to DNA. To confirm the specificity of the DNA pro-
tein interaction, a 100-fold excess of cold probes was used 
as a competitor to inhibit the binding activity of NF-κB at 
45 min after infection. As shown in Figure 1B, cold probes 
completely inhibited the DNA binding activity of NF-κB, in-
dicating that the increased binding is specific to the NF-κB-
binding sequence. Collectively, these findings suggest that S. 
aureus can induce activation of NF-κB in human osteoblasts 
in a time-dependent manner. 
S. aureus induced IκB degradation and NF-κB activa-
tion in human osteoblasts in a dose-dependent manner 
to determine the effect of the infectious dose on IκBa 
degradation, human osteoblats were infected with S. au-
reus for 30 min at the indicated MOIs. S. aureus-infected 
cells demonstrated IκBa degradation substantially in-
creased from MOI of 25 to 500 at 30 min (Figure 2A). 
To further determine the infectious doses on the roles 
of NF-κB DNA binding activity in human osteoblasts, 
NF-κB DNA binding activity from cells infected with 
S. aureus at 45 min quickly increased from an MOI of 25 
to 250 (Figure 2B), but started to decline when the MOI 
reached to 500. These results indicate that S. aureus can 
induce activation of NF-κB in human osteoblasts in a 
dose-dependent manner. Activation of NF-κB signaling 
pathway by S. aureus regulated the secretion of IL-6 and 
MCP-1 in human osteoblats.
S. aureus-infected human osteoblasts can significantly 
augment IL-6 and MCP-1 secretion at 24 h postinfection 
in vitro.3,4 Therefore, in our present study, we examined the 
supernatants of human osteoblasts at 24 h postinfection of 
S. aureus to determine if activation of NF-κB signaling path-
way by S. aureus regulates the secretion of IL-6 and MCP-
1 in human osteoblasts. As shown in Figure 3, uninfected 
cells (controls) could secrete IL-6 (0.22 ng/mL) and MCP-1 
(0.84 ng/mL), respectively. However, the secretion of IL-6 
and MCP-1 in the supernatants of human osteoblasts infect-
ed with S. aureus at an MOI of 250 for 1 h was significantly 
Figure 2: Dose-dependent activation of NF-kB signaling 
pathway by Staphylococcus aureus in human osteoblasts. 
Human osteoblasts were either uninfected (0 min) or infected 
with Staphylococcus aureus at the indicated multiplicity of 
infections (MOI). Immunoblot demonstrated cytosoic IkBa 
degradation at 30 min postinfection (A) and EMSA showed 
nuclear NF-kB activation at 45 min postinfection (B) in human 
osteoblasts. The exposed film is representative of results 
from three independent experiments.
Figure 3: Effect of carbobenzoxyl-l-leucinyl-l-leucinyl-l-leucinal 
(Z-LLL-al), an inhibitor of NF-kB, on the secretion of MCP-1 
and IL-6 in human osteoblasts infected with Staphylococcus 
aureus. Human osteoblasts were uninfected or infected with 
Staphylococcus aureus (S. aureus) at a multiplicity of infections 
(MOI) of 250 for 1 h or pretreated with Z-LLL-al at different 
concentrations for 1 h, then infected with S. aureus at an MOI 
of 250 for 1 h. Following infection, the cells were washed 
and grown in the culture medium for 24 h, and then the 
culture supernatants were collected. IL-6 and MCP-1 in 
the culture supernatants were measured with enzyme-linked 
immunosorbent assay (ELISA) kits. Data are presented as mean 
± SD from three independent experiments. Statistical analysis 
comparing groups was performed by ANOVA and SNK test. 
* p < 0.05, cells infected with S. aureus versus controls, # p 
< 0.05, cells infected with S. aureus versus cells pretreated 
with different concentrations of Z-LLL-al prior to infection of 
S. aureus.
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enhanced to 3.58 ± 0.31 ng/mL (p < 0.05) and 6.48 ± 0.30 
ng/mL (p < 0.05), compared with controls, respectively. In 
addition, Figure 3 also shows that the secretion of Il-6 and 
MCP-1 in the supernatants of human osteoblasts infected 
with S. aureus were suppressed by the addition of Z-LLL-
al (1 to 10 µM) in a dose-dependent manner, and IL-6 se-
cretion was reduced from 3.58 ± 0.31 to 3.27 ± 0.18, 2.30 
± 0.20 (p < 0.05), 0.89 ± 0.13 ng/mL (p < 0.05) and MCP-
1 secretion was reduced from 6.48 ± 0.30 to 5.52 ± 0. 22 
(p < 0.05), 3.36 ± 0.26 (p < 0.05), 1.52 ± 0.19 ng/mL (p < 0.05) 
at 1, 5, 10 µM Z-LLL-al, respectively. 
DISCUSSION
This study shows that S. aureus can activate NF-κB in hu-
man osteoblasts in a time and dose-dependent manner and 
S. aureus-activated NF-κB signaling pathway in human os-
teoblasts regulates the secretion of IL-6 and MCP-1.
The nuclear translocation of NF-κB is regulated by the 
cytoplasmic inhibitory species IκBa via its binding to 
the nuclear localization sequence of p65; degradation of 
IκBa triggers the activation of NF-κB.8,9 In our current study, 
activation of NF-κB by S. aureus in human osteoblasts has 
been demonstrated by two different methods. First, our im-
munoblot experiments demonstrated that degradation of 
cytoplasmic IκBa in S. aureus-infected human osteoblasts 
occurred in a time and dose-dependent manner (Figures 1A 
and 2A). Second, correlated IκBa degradation with NF-κB 
DNA binding activity, our findings by EMSA confirmed that 
nuclear proteins from S. aureus-infected human osteoblasts 
could stimulate the DNA binding activity of NF-κB in a time 
and dose-depenent manner (Figures 1B and 2B). 
In addition, we demonstrated that S. aureus-activated 
NF-κB signaling pathway in human osteoblasts regulates the 
secretion of IL-6 and MCP-1. As shown in Figure 3, human 
osteoblats infected with S. aureus at MOI of 250 significant-
ly augment IL-6 (p < 0.05) and MCP-1 (p < 0.05) secretion 
compared with controls, respectively. These results are con-
sistent with previous studies suggesting that S. aureus could 
stimulate osteoblasts to secrete high levels of interleukin-6 
and monocyte chemoattractant protein-1.3,4 Furthermore, 
Figure 3 also demonstrated that the secretion of IL-6 and 
MCP-1 in the supernatants of S. aureus-infected human oste-
oblats were significantly suppressed by the addition of Z-LLL-
al, an inhibitor of NF-κB,12 in a dose-dependent manner, sug-
gesting that S. aureus-activated NF-κB signaling pathway in 
human osteoblasts regulates the secretion of IL-6 and MCP-1. 
These findings are consistent with previous studies suggesting 
that NF-κB signaling pathway can regulate the secretion of IL-
613 and MCP-1.26,27 Indeed, the overall infectious process that 
human osteoblasts were exposed to S. aureus clearly involved 
a variety of converging signaling transduction pathway; it is 
possible that S. aureus may activate another signaling pathway 
to regulate the secretion of IL-6 and MCP-1. 
NF-κB is the predominantly modulated transcription 
factor functioning in immune and inflammatory response 
to microbial ligands by mediating signaling from the Toll-
like receptors (TLRs).8,28 TLRs can recognize bacterial 
cell components such as M protein,29 lipoteichoic acid,30 
LPS, peptidoglycans and lipopeptides, flagella and bacte-
rial DNA.28,31,32 The different TLRs recognize different li-
gands in a pathogen-associated molecular pattern. It has 
been reported that a number of these TLR homologues are 
present on osteoblasts, such as TLR2,33,34 TLR4,34,35 TLR5,36 
and TLR9.37 We are now in the process of exploring if the 
pathogen associated molecular pattern between TLRs of S. 
aureus-infected human osteoblasts and S. aureus cell com-
ponents is a predominant transcriptional factor that regu-
lates the activation of NF-κB. 
In conclusion, our results demonstrate for the first time that 
S. aureus can activate NF-κB in human osteoblasts in response 
to S. aureus infection, and activation of NF-κB by S. aureus regu-
lates the secretion of IL-6 and MCP-1 in human osteoblasts. 
The NF-κB transcription factor regulates a number of genes in-
volved in a wide variety of biological processes.38 Further investi-
gation of the effects of S. aureus on activation of NF-κB in human 
osteoblast may provide us with more insight into the regulation 
of the immune mechanisms in osteomyelitis. More understand-
ing about the pathogenesis of osteomyelitis may provide new 
therapeutic targets for the treatment of osteomyelitis.
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